Celano Michael 4
4 · Larimar Therapeutics, Inc. · Filed Feb 2, 2023
Insider Transaction Report
Form 4
Celano Michael
Chief Financial Officer
Transactions
- Award
Common Stock
2023-01-31+76,000→ 107,746 total - Award
Stock Option (Right to Buy)
2023-01-31+120,000→ 120,000 totalExercise: $4.94Exp: 2033-01-31→ Common Stock (120,000 underlying)
Footnotes (2)
- [F1]Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
- [F2]The option vests 25% on January 31, 2024, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.